Related Experiment Video
Updated: Jun 17, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
One-hit effects and cancer
Maria D Iniesta1, Janet Chien, Max Wicha
1Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, 48109, USA.
Germ-line BRCA1 or BRCA2 mutations can alter cellular pathways even in microscopically normal tissues. Bellacosa et al. provide crucial insights into the biology of these carriers, advancing our understanding of BRCA-related genetic alterations.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Biology
Background:
- Germ-line mutations in BRCA1 or BRCA2 genes significantly increase cancer risk.
- Understanding the biological consequences of these mutations is critical for early detection and prevention strategies.
- The role of microscopically normal tissues in carriers of these mutations remains an area of active investigation.
Discussion:
- Bellacosa et al. offer a perspective on the biology of tissues that appear normal under microscopy in individuals with germ-line BRCA1 or BRCA2 mutations.
- This work highlights the importance of considering sub-cellular or molecular alterations in seemingly healthy tissues.
- The study emphasizes the need to explore the functional impact of one inactivated BRCA allele.
Key Insights:
- Microscopically normal tissues in BRCA mutation carriers may harbor significant biological alterations.
- Identifying altered pathways in these tissues is a key step toward understanding disease development.
- This research contributes to a deeper comprehension of the heterozygous state of BRCA genes.
Outlook:
- Further research is needed to fully elucidate the molecular pathways affected by BRCA1/2 mutations in normal tissues.
- These findings may inform the development of novel biomarkers for cancer risk assessment in carriers.
- Continued investigation into the biology of BRCA carriers will be essential for personalized cancer prevention and treatment.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

